Wednesday, May 18, 2016

BRIEF-Chugai Pharmaceutical announces results of Japanese phase III study of Alecensa

* Announced results of Japanese phase III study of Alecensa

in Alk fusion gene positive non-small cell lung cancer

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)